The presence of PPM1D protein-stabilizing PTVs in the blood cells of patients with several types of solid tumors correlates with worse outcomes31,33–36,82 Our study suggests a possible mechanism linking the presence of clonal expansions of blood cells bearing PPM1D PTV mutations with worse outcomes for patients with neoplastic disease. This evidence concerns the gene PPM1D and neoplasm.